Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Frontiers in Microbiology|June 14, 2021
Characterization of the Complete Mitochondrial Genome of Basidiomycete Yeast Hannaella oryzae: Intron Evolution, Gene Rearrangement, and Its PhylogenyQiang Li, Lijiao Li, Huiyu Feng, et al.
International Journal of Biological Macromolecules|January 21, 2021
The first eleven mitochondrial genomes from the ectomycorrhizal fungal genus (Boletus) reveal intron loss and gene rearrangementQiang Li, Peng Wu, Lijiao Li, et al.
Biomaterials|August 16, 2025
Adaptive cationic peptide bundles hydrogel for the repair of infected mandibular defectsYimin Sun, Xuetao Yang, Yin Liu, et al.
The Annals of Thoracic Surgery|February 5, 2013
Clinical outcome of juvenile myasthenia gravis after extended transsternal thymectomy in a chinese cohortChao Cheng, Zhenguo Liu, Fenghua Xu, et al.
Transfusion|September 1, 2021
Immunoadsorption with staphylococcal protein A column in autoimmune encephalitisJiaxin Chen, Li Feng, Hongyan Zhou, et al.
BMC Neurology|February 26, 2025
Fast-acting treatment of myasthenic crisis with efgartigimod from the perspective of the neonatal intensive care unitFangyi Shi, Rong Lai, Li Feng, et al.
Acta Neurologica Scandinavica|August 8, 2020
Thymomatous myasthenia gravis: 10-year experience of a single centerJiaxin Chen, Wenjin Shang, Yin Chen, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 27, 2013
The effect of steroid treatment and thymectomy on bone age and height development in juvenile myasthenia gravisHaiyan Wang, Zhe Su, Chuanming Luo, et al.
Frontiers in Immunology|August 13, 2024
Efgartigimod as a promising add-on therapy for myasthenic crisis: a prospective case seriesJie Song, Haiyan Wang, Xiao Huan, et al.
Frontiers in Neurology|December 4, 2024
Efgartigimod treatment in patients with anti-MuSK-positive myasthenia gravis in exacerbationFangyi Shi, Jiaxin Chen, Li Feng, et al.
Pageof 7